Albumin binding ligands and albumin conjugate uptake by cancer cells
2011

Albumin Binding and Cancer Cell Uptake

publication Evidence: moderate

Author Information

Author(s): Eva Frei

Primary Institution: German Cancer Research Center and National Center for Tumor Diseases

Hypothesis

What happens to drugs transported by albumin when they come into contact with cancer cells?

Conclusion

The study suggests that albumin plays a crucial role in the uptake and release of drugs in cancer cells.

Supporting Evidence

  • Albumin is crucial for transporting drugs in the bloodstream.
  • Insulin detemir has a longer half-life due to its binding to albumin.
  • Clinical studies show that albumin can help target drugs to tumors.

Takeaway

This study looks at how a protein called albumin helps carry drugs to cancer cells, which can help doctors treat cancer better.

Methodology

The review summarizes existing literature on albumin's role in drug transport and cellular uptake.

Limitations

The exact mechanisms of albumin uptake by cancer cells are not fully understood.

Digital Object Identifier (DOI)

10.1186/1758-5996-3-11

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication